Hannah Elam

Trainee Solicitor
London, EIP Europe LLP

Hannah is a Trainee Solicitor in EIP Legal. Prior to joining EIP she spent five years as an IP litigation paralegal at a specialist IP firm where she was primarily involved in contentious life sciences disputes with a focus on complex patent litigation in the pharmaceutical and biotechnology fields. Hannah has been involved in some of the most high-profile recent cases in these sectors, including Eli Lilly & Others v Genentech, Astex v AstraZeneca and GSK v Wyeth.

Hannah holds a master’s degree in Management of Intellectual Property and a research master’s in Molecular Cell Biology. She also completed the Graduate Diploma in Law and the Legal Practicing Course at BPP University while working full time. Hannah is a native Swedish speaker.


  • Eli Lilly & Others v Genentech: Lead paralegal for Genentech in a declaration of non-infringement and SPC invalidation action concerning Lilly’s originator product ixekizumab (Taltz).
  • Astex v AstraZeneca: Lead paralegal for AZ in the successful appeal of the first instance decisions concerning a R&D collaboration agreement for BACE inhibitors for Alzheimer's disease.
  • GSK v Wyeth: Lead paralegal for Wyeth in the successful defence of a high value revocation and declaration of non-infringement action concerning Wyeth’s Meningitis B vaccine Trumenba.

Education and qualifications


  • 2018 — 2019
    Legal Practice Course, BPP University
  • 2014 — 2016
    Graduate Diploma in Law, BPP University
  • 2012 — 2013
    MSc Management of Intellectual Property, Queen Mary University of London
  • 2011 — 2012
    MSc by Research Molecular Cell Biology, University of Edinburgh
  • 2008 — 2011
    BSc Medical Biochemistry, University of Leicester

Career history

  • 2019 — present
    Trainee Solicitor , EIP
  • 2014 — 2019
    IP Litigation Paralegal, Marks & Clerk Solicitors

Languages spoken

  • Swedish (Fluent)